CALYPTE BIOMEDICAL CORP
CALYPTE BIOMEDICAL CORP (HIV) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Feb 8, 2006 involved a transaction of 311,736 shares valued at $0.
HIV Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 8, 2006 | I. Gale Roger | Executive | Award | 311,736 | $N/A | $0 | |
| Jan 4, 2006 | I. Gale Roger | Executive | Award | 1,000,000 | $N/A | $0 |
HIV Insider Activity Summary
Who Is Buying HIV Stock?
No significant insider buying has been recorded for HIV in the recent period.
Who Is Selling HIV Stock?
No significant insider selling has been recorded for HIV in the recent period.
Is CALYPTE BIOMEDICAL CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HIV is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
HIV Frequently Asked Questions
Understanding HIV Insider Activity
Insider trading at CALYPTE BIOMEDICAL CORP (HIV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading HIV stock, having executed 2 transactions in the past 90 days. The most active insider is Roger I. Gale (Executive), who has made 2 transactions totaling $0.
Related Tools
Track CALYPTE BIOMEDICAL CORP Insider Activity
Get notified when executives and directors at HIV file new Form 4 transactions